Technology News and Research

RSS

Nanotherapeutics receives contract from DOD to support clinical trial for treating dehisced surgical wounds

Nanotherapeutics, Inc. announced that it has been awarded a contract by the U.S. Department of Defense to support a clinical trial for treating dehisced surgical wounds with the Company's NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.

4 Nov 2010

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

"For brain cancer patients after surgery, the combined DC-CIK and stem cell therapy from Cellonis Biotechnologies can be a very effective method in preventing cancer recurrence," says renowned cancer doctor Dr. Dinggang Li.

4 Nov 2010

New noninvasive technique to detect methemoglobin level

Potentially harmful levels of methemoglobin which can build up in patients receiving certain anesthetics are detectable using a new, noninvasive monitoring technique called pulse CO-oximetry, reports a study in the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

4 Nov 2010

Bio-Path awarded $244,479 federal grant for Liposomal Grb-2 Phase I clinical trial

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has received a grant of $244,479 from the United States Government to help fund the Company's Phase I clinical trial of its lead cancer drug candidate Liposomal Grb-2. The amount of funds awarded was the maximum allocation allowed under the program.

4 Nov 2010

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Regado Biosciences, Inc., a private biopharmaceutical company leading the development of antithrombotic aptamers with matched active control agents, announced today that it has received funding from the United States government under the Qualifying Therapeutic Discovery Project (QTDP) grants program to advance the development of the company's three programs, REG1, REG2 and REG3.

4 Nov 2010

Coronado completes series of private financings

Coronado Biosciences, Inc., a privately held company engaged in innovative oncology drug development, announced completion of a series of private financings in 2010, resulting in aggregate gross proceeds to the Company of approximately $21.6 million.

4 Nov 2010

Georgia Tech hosts symposium to discuss sickle cell disease

Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder. The symposium begins at Georgia Tech's Institute for Bioengineering and Bioscience on November 4 and concludes the evening of November 5.

4 Nov 2010

NinePoint Medical awarded $250,000 grant from Qualifying Therapeutic Discovery Project Program

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has been awarded a grant of approximately $250,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The QTDP's grants and tax credits are provided under the new section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010.

4 Nov 2010

Quick-Med Technologies awarded $244,000 QTDP grant to advance antimicrobial technology for wound care

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today it has been awarded by the U.S government under Qualifying Therapeutic Discovery Project (QTDP) to advance the development of the company's NIMBUS® technology for wound dressings and wound drains.

4 Nov 2010

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.

4 Nov 2010

MicroPhage receives $977,916 QTDP grant for development of MRSA/MSSA Blood Culture Test

MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.

4 Nov 2010

GPUs in video games foster revolution in development of new life-saving drugs

Parents may frown upon video games, but the technology used in the wildly popular games is quietly fostering a revolution in speeding the development of new products and potentially life-saving drugs. That's the topic of an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

4 Nov 2010

FDA clears GE Healthcare's CARESCAPE Monitor B650 patient monitoring solution

GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.

4 Nov 2010

Electrolytic Ozone completes Series A funding

Electrolytic Ozone Inc. (EOI) today announced completion of Series A funding. EOI develops and manufactures ultra-compact, safe and reliable ozone generators that harness the benefits of ozone to improve the safety and quality of the human environment. EOI ozone cells enable innovative sanitization, deodorization and preservation applications of ozone for consumer, food safety, health and medical uses.

4 Nov 2010

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Idaho Technology, Inc. (ITI) announced today that it has filed a submission with the U.S. Food and Drug Administration for 510(k) clearance to market its FilmArray Respiratory Panel (RP) as an in vitro diagnostic product for patients with symptoms of upper respiratory tract infection.

4 Nov 2010

New laparoscopic instrument mimics human index finger

Microline Surgical, a leading manufacturer of reposable instruments for minimally invasive surgery, today announced the launch of its LapFinger™ finger activated laparoscopic instrument. LapFinger mimics the ultimate dissection tool - the human index finger - enabling surgeons to dissect with confidence, retract with strength and palpate with feel.

4 Nov 2010

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2010, and company highlights.

4 Nov 2010

BioClinica third quarter service revenues increase to $15.8 million

BioClinica®, Inc., a global provider of clinical trial management services, today announced its financial results for the three and nine months ended September 30, 2010.

From Clario 3 Nov 2010

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Revolutions Medical Corporation announced today that due to the launch of its 3ml RevVac Safety SyringeTM during the Medica show in Dusseldorf, Germany and the enormous interest that the launch has received from healthcare professionals and corporations in Europe, the company will host an additional reception in London on Saturday, November 20th from 7:30 PM - 9:30 PM at the Landmark Hotel, Tower Suite.

3 Nov 2010

Top 10 Medical Innovations for 2011

From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases.

3 Nov 2010

Technology News and Research

Nanotherapeutics receives contract from DOD to support clinical trial for treating dehisced surgical wounds

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

New noninvasive technique to detect methemoglobin level

Bio-Path awarded $244,479 federal grant for Liposomal Grb-2 Phase I clinical trial

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Coronado completes series of private financings

Georgia Tech hosts symposium to discuss sickle cell disease

NinePoint Medical awarded $250,000 grant from Qualifying Therapeutic Discovery Project Program

Quick-Med Technologies awarded $244,000 QTDP grant to advance antimicrobial technology for wound care

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

MicroPhage receives $977,916 QTDP grant for development of MRSA/MSSA Blood Culture Test

GPUs in video games foster revolution in development of new life-saving drugs

FDA clears GE Healthcare's CARESCAPE Monitor B650 patient monitoring solution

Electrolytic Ozone completes Series A funding

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

New laparoscopic instrument mimics human index finger

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

BioClinica third quarter service revenues increase to $15.8 million

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Top 10 Medical Innovations for 2011

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News